City of Hope provides $2.3 mln in Series A funding in Lumināt
City of Hope, a research and treatment center for cancer, diabetes and other diseases, has provided $2.3 million in Series A funding to Lumināt, which develops advance care planning. City of Hope also has granted Lumināt a license to develop and market the company's touch-screen tool to assess patient needs. Lumināt raised initial seed funding of $750,000. The Series A funding is the first of its kind from City of Hope.
11 December 2014•3 mins read
